AXS 05
Axsome to Pursue FDA Approval for Alzheimer’s Agitation Treatment Despite Mixed Trial Results
Axsome Therapeutics, Alzheimer’s disease agitation, FDA approval, mixed trial data, AXS-05
Actionable Insights Powered by AI
Axsome Therapeutics, Alzheimer’s disease agitation, FDA approval, mixed trial data, AXS-05